Neuroprotection in acute ischemic stroke: are we there yet?
Shuaib
Ashfaq
A
Stroke Research Laboratory, University of Alberta, Edmonton, Canada. ashfaq.shuaib@ualberta.ca
D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator